0002024197-24-000002.txt : 20241029 0002024197-24-000002.hdr.sgml : 20241029 20241029114336 ACCESSION NUMBER: 0002024197-24-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241029 DATE AS OF CHANGE: 20241029 EFFECTIVENESS DATE: 20241029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nodal Therapeutics, Inc. CENTRAL INDEX KEY: 0002024197 ORGANIZATION NAME: IRS NUMBER: 992312011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-515359 FILM NUMBER: 241403743 BUSINESS ADDRESS: STREET 1: 1804 EDGEWATER PARKWAY CITY: SILVER SPRING STATE: MD ZIP: 20903 BUSINESS PHONE: 608-215-5779 MAIL ADDRESS: STREET 1: 1804 EDGEWATER PARKWAY CITY: SILVER SPRING STATE: MD ZIP: 20903 D/A 1 primary_doc.xml X0708 D/A LIVE 0002024197 Nodal Therapeutics, Inc. 1804 EDGEWATER PARKWAY SILVER SPRING MD MARYLAND 20903 608-215-5779 DELAWARE None None Corporation true 2024 Christopher Jewell 1804 Edgewater Parkway Silver Spring MD MARYLAND 20903 Executive Officer Director Jonathan S. Bromberg 1804 Edgewater Parkway Silver Spring MD MARYLAND 20903 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0002024197-24-000001 2024-05-23 false true true Simple Agreement for Future Equity false 0 250000 250000 0 false 1 0 0 0 false Nodal Therapeutics, Inc. /s/ Christopher Jewell Christopher Jewell Chief Executive Officer 2024-10-29